Julia Harwardt

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Technische Universität Darmstadt(Current)

Scripps Research Institute

Merck KGaA, Darmstadt (Germany)

Ferring Pharmaceuticals (Switzerland)

Julia Harwardt is an author at Technische Universität Darmstadt specializing in oncology, antibody-dependent cellular cytotoxicity, and cancer immunotherapy.

Publications per year

2021–2024

Publications

Milking the Cow: Cattle-Derived Chimeric Ultralong CDR-H3 Antibodies and Their Engineered CDR-H3-Only Knobbody Counterparts Targeting Epidermal Growth Factor Receptor Elicit Potent NK Cell-Mediated Cytotoxicity

Lukas Pekar, Daniel Klewinghaus, Paul Arras et al. · Frontiers in Immunology · 2021 · 19 citations · Full text

Pharmacy, Immunology, Oncology +17

On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality

Monica L. Fernández‐Quintero, Enrico Guarnera, Djordje Müsil et al. · Protein Science · 2024 · 19 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Conditional activation of an anti-IgM antibody-drug conjugate for precise B cell lymphoma targeting

Katrin Schoenfeld, Julia Harwardt, Jan Habermann et al. · Frontiers in Immunology · 2023 · 12 citations · Full text

Pharmacy, Immunology, Oncology +17

Better safe than sorry: dual targeting antibodies for cancer immunotherapy

Katrin Schoenfeld, Julia Harwardt, Harald Kolmar · Biological Chemistry · 2024 · 11 citations

Pharmacy, Medicinal Chemistry, Oncology +17

TriTECM: A tetrafunctional T-cell engaging antibody with built-in risk mitigation of cytokine release syndrome

Stefania Carrara, Julia Harwardt, Julius Grzeschik et al. · Frontiers in Immunology · 2022 · 10 citations · Full text

Medicine, Immunology, Oncology +16

1–5 of 6